arrow
S

Stella D'Oronzo

lum university
H指数:25
被引数:1,860

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of anti-osteoporotic medications in the management of glucocorticoid-induced osteoporosis: a systematic review and network meta-analysis on behalf of the ECTS clinical action group

糖皮质激素诱导性骨质疏松管理中抗骨质疏松药物的有效性:ECTS临床行动小组的系统性综述和网络Meta分析

2026-08-070
PRE
Bone Adverse Events in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Comprehensive Review of the Literature from the Clinical Action Group of the European Calcified Tissue Society

癌症患者接受免疫检查点抑制剂治疗时的骨骼不良事件:欧洲钙化组织学会临床行动小组对文献的全面综述

2026-02-120
PRE
Late endocrine-metabolic complications in survivors of young adult and adult-onset cancers: comprehensive evaluation and strategies for management. An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical review

年轻成年及成年发病癌症幸存者的晚期内分泌-代谢并发症:全面评估与管理策略。意大利医学肿瘤学会(AIOM)、意大利医学糖尿病学会(AMD)、意大利糖尿病学会(SID)、意大利内分泌学会(SIE)、意大利药理学学会(SIF)多学科批判性综述

2025-12-030
OAAI
Treating osteoporosis with denosumab or bisphosphonates in the long term: facts, uncertainties and assumptions. A narrative review by the clinical action group of the European Calcified Tissue Society (ECTS)

长期使用地诺单抗或双膦酸盐治疗骨质疏松症:事实、不确定性与假设。欧洲钙化组织学会(ECTS)临床行动小组的叙事综述。

Bone
IF3.6
2025-07-260
PRE
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies

实体肿瘤和糖尿病患者疫苗接种:现有证据与建议。一份来自多学科科学学会专家组的立场声明

2025-04-230
OA
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
2024-06-276
OAAI
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group
2024-05-010
OAAI
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper

癌症患者的糖尿病管理。意大利医学肿瘤学协会,意大利医学糖尿病学家协会,意大利糖尿病学会,意大利内分泌学会和意大利药理学学会多学科共识立场文件

2023-12-017
OAAI
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view

MiRNA失调是2型糖尿病和癌症发展的共同途径的基础: 意大利医学肿瘤学协会 (AIOM)/意大利医学糖尿病学家协会 (AMD)/意大利糖尿病学会 (SID)/意大利内分泌学会 (SIE)/意大利药理学会 (SIF) 多学科批判性观点

2023-06-0114
OAAI
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper

肿瘤学中的皮质类固醇: 使用,过度使用,适应症,禁忌症。意大利医学肿瘤学协会 (AIOM)/意大利医学糖尿病学家协会 (AMD)/意大利内分泌学会 (SIE)/意大利药理学学会 (SIF) 多学科共识立场文件

2022-12-0114
OAAI
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper

代谢紊乱和胃肠胰神经内分泌肿瘤 (gep-nets): 它们如何相互影响?意大利医学肿瘤学协会 (AIOM)/意大利医学糖尿病学家协会 (AMD)/意大利内分泌学会 (SIE)/意大利药理学学会 (SIF) 多学科共识立场文件

2022-01-0118
PRE